These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38070460)

  • 1. Tenecteplase in Pediatric Stroke: Ready or Not.
    Wilson JL; Waak M; Barry M; Jordan LC; Sun LR
    Pediatr Neurol; 2024 Feb; 151():17-20. PubMed ID: 38070460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes with IV tenecteplase and IV alteplase for acute ischemic stroke with or without thrombectomy in real-world settings in the United States.
    Qureshi AI; Baskett WI; Bains NK; French BR; Siddiq F; Gomez CR; Shyu CR
    J Stroke Cerebrovasc Dis; 2023 Feb; 32(2):106898. PubMed ID: 36493706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that Tenecteplase Is Noninferior to Alteplase for Acute Ischemic Stroke: Meta-Analysis of 5 Randomized Trials.
    Burgos AM; Saver JL
    Stroke; 2019 Aug; 50(8):2156-2162. PubMed ID: 31318627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tenecteplase for Acute Ischemic Stroke Treatment.
    Baird AE; Jackson R; Jin W
    Semin Neurol; 2021 Feb; 41(1):28-38. PubMed ID: 33472268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-Term Efficacy Outcomes of Tenecteplase versus Alteplase for Acute Ischemic Stroke: A Meta-Analysis of 5 Randomized Trials.
    Requiao LE; Oliveira RS; Reis LS; B Assis AP; G Moreno BN; Cordeiro LR; Solla DF
    Neurol India; 2022; 70(4):1454-1459. PubMed ID: 36076643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety of Intravenous Tenecteplase Bolus in Acute Ischemic Stroke: Results of Two Open-Label, Multicenter Trials.
    Ramakrishnan TCR; Kumaravelu S; Narayan SK; Buddha SS; Murali C; Majeed PHA; Meenakshi-Sundaram S; Wadia RS; Sharma V; Basu I; Vijaya P; Salam KA; Barmare S; Vaid Z; Nirmal Raj KK; Wattamwar PR; Asokan K; Dhonge V; Nellikunja S; Namjoshi D; Srinivasa R; Laddhad DS; Deshpande SD; Raghunath B; Kalita J; Kumar M; Misra UK; Pradeep M;
    Am J Cardiovasc Drugs; 2018 Oct; 18(5):387-395. PubMed ID: 29948822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tenecteplase versus alteplase before mechanical thrombectomy: experience from a US healthcare system undergoing a system-wide transition of primary thrombolytic.
    Hendrix P; Collins MK; Griessenauer CJ; Goren O; Melamed I; Weiner GM; Dalal SS; Kole MJ; Noto A; Schirmer CM
    J Neurointerv Surg; 2023 Nov; 15(e2):e277-e281. PubMed ID: 36414389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tenecteplase for the treatment of acute ischemic stroke: A review of completed and ongoing randomized controlled trials.
    Coutts SB; Berge E; Campbell BC; Muir KW; Parsons MW
    Int J Stroke; 2018 Dec; 13(9):885-892. PubMed ID: 30035698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter exploration of tenecteplase transition factors: A quantitative analysis.
    Prasad S; Jones EM; Gebreyohanns M; Kwon Y; Olson DM; Anderson JA; Savitz SI; Cruz-Flores S; Warach SJ; Rhodes CE; Goldberg MP; Ifejika NL
    J Stroke Cerebrovasc Dis; 2024 Apr; 33(4):107592. PubMed ID: 38266690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tenecteplase in Acute Stroke: What About the Children?
    Sun LR; Wilson JL; Waak M; Kiskaddon A; Goldenberg NA; Jordan LC; Barry M
    Stroke; 2023 Jul; 54(7):1950-1953. PubMed ID: 37226774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determining the optimal dose of tenecteplase before endovascular therapy for ischemic stroke (EXTEND-IA TNK Part 2): A multicenter, randomized, controlled study.
    Campbell BC; Mitchell PJ; Churilov L; Yassi N; Kleinig TJ; Yan B; Thijs V; Desmond PM; Parsons MW; Donnan GA; Davis SM
    Int J Stroke; 2020 Jul; 15(5):567-572. PubMed ID: 31564231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy and safety of intravenous thrombolysis with tenecteplase versus alteplase for acute ischemic stroke: a systematic review and meta-analysis.
    Wei H; Fu B; Yang C; Huang M
    Neurol Sci; 2023 Sep; 44(9):3005-3015. PubMed ID: 37061572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tenecteplase-tissue-type plasminogen activator evaluation for minor ischemic stroke with proven occlusion.
    Coutts SB; Dubuc V; Mandzia J; Kenney C; Demchuk AM; Smith EE; Subramaniam S; Goyal M; Patil S; Menon BK; Barber PA; Dowlatshahi D; Field T; Asdaghi N; Camden MC; Hill MD;
    Stroke; 2015 Mar; 46(3):769-74. PubMed ID: 25677596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in the management of acute ischemic stroke.
    Nair R; Wagner AN; Buck BH
    Curr Opin Neurol; 2023 Apr; 36(2):147-154. PubMed ID: 36762632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tenecteplase vs Alteplase Before Endovascular Therapy in Basilar Artery Occlusion.
    Alemseged F; Ng FC; Williams C; Puetz V; Boulouis G; Kleinig TJ; Rocco A; Wu TY; Shah D; Arba F; Kaiser D; Di Giuliano F; Morotti A; Sallustio F; Dewey HM; Bailey P; O'Brien B; Sharma G; Bush S; Dowling R; Diomedi M; Churilov L; Yan B; Parsons MW; Davis SM; Mitchell PJ; Yassi N; Campbell BCV;
    Neurology; 2021 Mar; 96(9):e1272-e1277. PubMed ID: 33408145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ST segment resolution in patients with tenecteplase-facilitated percutaneous coronary intervention versus tenecteplase alone: Insights from the Combined Angioplasty and Pharmacological Intervention versus Thrombolysis ALone in Acute Myocardial Infarction (CAPITAL AMI) trial.
    So DY; Ha AC; Davies RF; Froeschl M; Wells GA; Le May MR
    Can J Cardiol; 2010 Jan; 26(1):e7-12. PubMed ID: 20101370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tenecteplase use in the management of acute ischemic stroke: Literature review and clinical considerations.
    Hailu K; Cannon C; Hayes S
    Am J Health Syst Pharm; 2022 Jun; 79(12):944-949. PubMed ID: 35020806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and Efficacy of Tenecteplase in Older Patients With Large Vessel Occlusion: A Pooled Analysis of the EXTEND-IA TNK Trials.
    Yogendrakumar V; Churilov L; Mitchell PJ; Kleinig TJ; Yassi N; Thijs V; Wu TY; Shah DG; Ng FC; Dewey HM; Wijeratne T; Yan B; Desmond PM; Parsons MW; Donnan GA; Davis SM; Campbell BCV;
    Neurology; 2022 Mar; 98(12):e1292-e1301. PubMed ID: 35017305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy and safety of tenecteplase versus alteplase for acute ischemic stroke: an updated systematic review, pairwise, and network meta-analysis of randomized controlled trials.
    Abuelazm M; Seri AR; Awad AK; Ahmad U; Mahmoud A; Albazee E; Kambalapalli S; Abdelazeem B
    J Thromb Thrombolysis; 2023 Feb; 55(2):322-338. PubMed ID: 36449231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination reperfusion therapy with eptifibatide and reduced-dose tenecteplase for ST-elevation myocardial infarction: results of the integrilin and tenecteplase in acute myocardial infarction (INTEGRITI) Phase II Angiographic Trial.
    Giugliano RP; Roe MT; Harrington RA; Gibson CM; Zeymer U; Van de Werf F; Baran KW; Hobbach HP; Woodlief LH; Hannan KL; Greenberg S; Miller J; Kitt MM; Strony J; McCabe CH; Braunwald E; Califf RM;
    J Am Coll Cardiol; 2003 Apr; 41(8):1251-60. PubMed ID: 12706917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.